Skip to main contentSkip to navigation
Sirius Investors

FWPAY Stock: Forward Pharma A/S Stock Price, Analysis & Insights

Get live FWPAY stock price $300.00, comprehensive Forward Pharma A/S stock analysis, charts, news, and expert forecast. Real-time FWPAY stock data and investment insights.

300.00
25.09%Today
FWPAYForward Pharma A/S • Other OTC • Healthcare
Market Cap
7.45M
Volume
4
52W High
882.86
52W Low
200.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both infl...

Company Information

CEO
Claus Bo Søndergaard Svendsen
Sector
Healthcare
Industry
Biotechnology
Employees
4

Contact Information

Address
Oestergade 24A
Country
DK

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Forward Pharma A/S shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Forward Pharma A/S
  • Investors should consider how Forward Pharma A/S fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

7.45M

P/E Ratio (TTM)

-10.56

Beta

1.02

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.